Creative Planning

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1540235 OVERLAND PARK, KS

Position in COLL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,496,543

+$516,415 QoQ

Shares Held

41,341

+39.5% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 280 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

Creative Planning holds $137,414,626 across 41 Drug Manufacturers - Specialty & Generic names. COLL ranks #16 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	1,240,848	$17,979,887
2	UTHR	UNITED THERAPEUTICS Corp	28,934	$15,677,309
3	VTRS	Viatris Inc	920,607	$14,619,238
4	NBIX	Neurocrine Biosciences Inc	76,818	$12,946,905
5	LNTH	Lantheus Holdings, Inc.	85,571	$9,493,246
6	TAK	Takeda Pharmaceutical Co Ltd	584,777	$9,373,974
7	ZTS	Zoetis Inc.	121,209	$8,710,078
8	HIMS	Hims & Hers Health, Inc.	225,206	$7,807,891

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,496,543	41,341	+39.5%	Shares	Defined	2026-08-13
2026-03-31	$980,128	29,638	+12.0%	Shares	Sole	2026-05-12
2025-12-31	$1,225,283	26,464	+5.1%	Shares	Sole	2026-02-17
2025-09-30	$880,977	25,178	+11.1%	Shares	Sole	2025-11-14
2025-06-30	$669,996	22,658	+83.5%	Shares	Sole	2025-08-08
2025-03-31	$368,677	12,351	-4.0%	Shares	Sole	2025-05-15
2024-12-31	$368,438	12,860	+75.4%	Shares	Defined	2025-02-14
2024-09-30	$283,230	7,330	+2.3%	Shares	Defined	2024-10-11
2024-06-30	$230,680	7,164	+33.4%	Shares	Sole	2024-08-15
2024-03-31	$208,541	5,372	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.